Accessibility Tools

Skip to main content

Neurological Master List of Peer Reviewed Studies

14 November 2021

Small fiber neuropathy: CNS inflammation after COVID-19 mRNA vaccination: a case series POTS: General Neuro side effects: 18 cases of idiopathic sensorineural hearing loss, tinnitus, and/or vertigo following Moderna/Pfizer: 3 cases of Tinnitus following mRNA vaccination: Tinnitus/Hearing Disturbances: Severe dyskinesia in Parkinson Patient following mRNA vaccination: Two cases of encephalopathy and seizures following Moderna: Acute disseminated encephalitis following Pfizer: Postvaccinal encephalitis following AstraZeneca: Acute encephalitis, myoclonus, and sweet syndrome after mRNA vaccine: Aseptic Meningitis following Pfizer: Tinnitus/cochleopathy following AstraZeneca: Trigeminal Neuralgia and cervical radiculitis after Pfizer: Amyotrophic neuralgia secondary to AstraZeneca: Neuralgic amyotrophy following mRNA vaccination: Gravis Flare Following Moderna: Acute Myelitis following AstraZeneca: Facial Palsy: cmab068/6311086 Bilateral facial weakness with paresthesia variant of GBS following AstraZeneca: Facial Weakness, extremity weakness, encephalopathy, and severe refractory ITP following Moderna: Facial Palsy: 36yo with Bells Palsy, left arm tingling/numbness/weakness following mRNA vaccination: 50yoM with Bells Palsy after Pfizer, ongoing symptoms after 21 days: 21yoF nurse with Bells Palsy following Pfizer: 61yoM with Bells Palsy after each dose of Pfizer: 57yoF with Bells Palsy <36 hours after 2nd dose of Pfizer: 34yoF with Bells Palsy 2 days after Moderna: Bells Palsy following mRNA and inactivated (CoronaVac) vaccines: a case series and nested Case-Control study: 2 cases of Sensory GBS following AstraZeneca: GBS following Johnson and Johnson: 4 cases of GBS following Astra Zeneca: GBS in elderly gentleman following 2nd dose of Pfizer: GBS following Pfizer: GBS after the first dose of Pfizer: GBS in a 25 yoF following 2nd dose of Pfizer: GBS 10 days after AstraZeneca: GBS 11 days after AstraZeneca: GBS following AstraZeneca: 7 cases of GBS following AstraZeneca: First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine: Patient’s first MS Flare following Pfizer: MS Flare following AZ: 2 cases of Parsonage Turner Syndrome following Moderna and Pfizer: Transient akathisia after Pfizer: Phantosmia: Optic neuritis and transverse myelitis in MS patient after Astrazeneca vaccination: Neuromyelitis optica spectrum disorder (NMOSD): Cytotoxic lesion of the Corpus Callousum following mRNA vaccination: Headache after AstraZeneca: a MultiCenter observational cohort center: Worsening Neuro-Oncologic Disease Symptoms following mRNA vaccination: Clinical characteristics of Headache following Pfizer, a multicenter observational cohort study: CVA and Thrombocytopenia following Astrazeneca: Cerebral venous sinus thrombosis after AstraZeneca, neurologic and radiological management: Cerebral Venous sinus thrombosis, review of European cases: 45 cases of Cerebral Venous thrombosis: Review of European data of Cerebral venous thrombosis with cytopenia, observed in Pfizer, Moderna, and AstraZeneca New onset psychosis after mRNA vaccine: Delirium in an elderly patient following vaccination: Delirium in an elderly patient following Pfizer: Neuro Autoimmune -